Here are five things to know about the transaction:
1. Mr. Cole sold 40,367 shares at $17.86 per share, average price.
2. The total value of the transaction was $720,954.62.
3. Mr. Cole now directly owns 308 shares of the company, valued at around $5,500.88.
4. K2M traded up yesterday, hitting $19.85 per share.
5. The company’s market cap is $783.4 million.
More articles on orthopedic devices:
OsteoMed launches ankle fusion plating system
Mesoblast gets patent for mesenchymal precursor cell technology—7 things to know
K2M closes follow-on offering with $35M
